RIABNI vs ZYDELIG

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. RIABNI and ZYDELIG are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RIABNI	ZYDELIG
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RITUXIMAB-ARRX	IDELALISIB
Manufacturer	Amgen Inc	Gilead Sciences Inc
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis	Lymphoid Leukemia, Non-Hodgkin Lymphoma

riabni zydelig

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

RITUXIMAB-ARRX

IDELALISIB

Manufacturer

Amgen Inc

Gilead Sciences Inc

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis

Lymphoid Leukemia, Non-Hodgkin Lymphoma

Frequently asked questions

Which is better-rated, Riabni or Zydelig?

By our independent rating, Riabni scores higher — 3.6 vs 3.5 out of 5 for Zydelig. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Riabni and Zydelig?

Riabni contains Rituximab-Arrx, while Zydelig contains Idelalisib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.